| Detailed information |
|---|
| CancerLivER ID | 2498 |
| Biomarker | TGM2 |
| Biomarker Name/Symbol (given in Publication) | Transglutaminase 2 or TGM2 |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | Serologic and histological biomarker of HCC and validated on independent dataset |
| Experimental Condition | HCC v/s normal |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC than non tumor |
| Level of significance | p < 0.05 |
| Source | Cell line, Tissue, Serum |
| PMID | 18646787 |
| Type of Biomarker | Diagnostic |
| Pathway | |
| Cohort | 61 specimens of clinical HCC cases; Hepatic cell lines:normal (HL-7702) and HCC(HepG2 and SK-HEP-1) cells; Validation dataset: Serum obtained from 109 HCC and 42 healthy controls |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s Normal |
| Year of Publication | 2008 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |